Collectively, in vivo experiments demonstrated that IMP2 knockdown inhibits the tumor growth and prognosis of the xenografts via the interaction of IMP2 with the ZFAS1/OLA1 axis through m6A-induced stability in CRC. This evidence concerns the gene IGF2BP2 and neoplasm.